University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Peroral Endoscopic Myotomy (POEM) for Esophageal Motility

Not Applicable

Completed

Conditions: Achalasia

Interventions: Procedure: POEM Procedure

First Posted Date: 2014-12-11

Last Posted Date: 2018-02-19

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 10

Registration Number: NCT02314741

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Reducing Heart Failure Re-admissions by Enhancing Sleep Apnea Treatment Adherence

Not Applicable

Completed

Conditions: Congestive Heart Failure
Sleep Apnea Syndromes

Interventions: Behavioral: AirCare App

First Posted Date: 2014-12-09

Last Posted Date: 2020-08-04

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 146

Registration Number: NCT02312765

Effects of Implicit Messaging by Cigarette Pack Color on Smoking Behaviors

Not Applicable

Completed

Conditions: Cigarette Smoking Behavior

Interventions: Other: Graphic Warning Label
Other: Text Warning Label

First Posted Date: 2014-11-25

Last Posted Date: 2019-04-16

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 316

Registration Number: NCT02301351

Locations: 🇺🇸
Center for Interdisciplinary Research on Nicotine Addiction, University of Pennsylvania, Philadelphia, Pennsylvania, United States

Impact of Active Choice on Advance Directive Completion Rates

Not Applicable

Completed

Conditions: Advance Directive Completion

Interventions: Behavioral: Mandatory active choice

First Posted Date: 2014-11-13

Last Posted Date: 2017-01-27

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 1279

Registration Number: NCT02289105

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Tau Imaging in Young Onset Dementia

Completed

Conditions: Posterior Cortical Atrophy (PCA)
Logopenic Progressive Aphasia
Alzheimer's Disease, Early Onset

Interventions: Drug: [18F]-T807 imaging tracer

First Posted Date: 2014-11-13

Last Posted Date: 2020-03-25

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 16

Registration Number: NCT02289118

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial

Phase 2

Completed

Conditions: End-Stage Renal Disease

Interventions: Drug: Spironolactone

First Posted Date: 2014-11-07

Last Posted Date: 2019-07-23

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 129

Registration Number: NCT02285920

Locations: 🇺🇸
Kidney Research Institute, University of Washington, Seattle, Washington, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

and more 1 locations

Circadian Brown Adipose Tissue Metabolism

Not Applicable

Completed

Conditions: Healthy

Interventions: Device: FDG PET/CT

First Posted Date: 2014-11-06

Last Posted Date: 2016-12-07

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 10

Registration Number: NCT02285270

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

[18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer

Phase 1

Active, not recruiting

Conditions: Breast Cancer
Breast Neoplasm

Interventions: Drug: [18F]ISO-1

First Posted Date: 2014-11-06

Last Posted Date: 2024-12-18

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 30

Registration Number: NCT02284919

Locations: 🇺🇸
University of Pennsylvania Hospital, Philadelphia, Pennsylvania, United States

Indocyanine Green for Solid Tumors

Phase 1

Completed

Conditions: Solid Tumor
Neoplasms

Interventions: Drug: Indocyanine Green (ICG)

First Posted Date: 2014-11-02

Last Posted Date: 2018-03-20

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 48

Registration Number: NCT02280954

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

CD19 Redirected Autologous T Cells for Hodgkin Lymphoma

Early Phase 1

Terminated

Conditions: Hodgkin Lymphoma With no Available Curative Treatment Options Who Have a Limited Prognosis

Interventions: Biological: RNA anti-CD19 CAR T cells

First Posted Date: 2014-10-29

Last Posted Date: 2023-06-22

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 4

Registration Number: NCT02277522

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy